The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the ...
Jason B. Pieper, DVM, MS, DACVD, talks about the multiple therapies available for cases of moderate and severe atopic dermatitis and delves into each option ...
With the help of prescription medications and a whole lot of moisturizing, it’s possible to keep dermatitis under control.
The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...
Many skin conditions appear differently in melanated skin, leading to misdiagnosis and poor treatment. Understanding these ...
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...
Nemluvio has received approval from the European Commission to treat moderate to severe atopic dermatitis and prurigo ...
Opzelura is a treatment for nonsegmental vitiligo in patients 12 and older, making it the first and only cream in the U.S.
Nemluvio is now the first approved monoclonal antibody that specifically targets interleukin-31 receptor alpha ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback